Tenaya Therapeutics Inc. TNYA on Friday reported interim Phase 1b/2 RIDGE-1 data showing its TN-401 gene therapy reduced ...

Researchers combined two modal decomposition techniques to better understand flow patterns inside the left ventricle that may ...

Findings from a new study have identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM), a heart ...

Findings from a study supported in part by the National Institutes of Health (NIH) have identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM), a heart condition with a ...

Findings from a study supported in part by the National Institutes of Health (NIH) have identified a new model for predicting ...

Following an acute heart attack, pathological remodeling processes occur in the heart. One consequence is so-called left ...

A large international study led by researchers at the University of Oxford and the University of Virginia (USA) has identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM) ...

Stephen Smay was born with half a working heart. But the Tewksbury resident and Lowell Catholic High School senior hasn’t let ...

Longeveron said the Food and Drug Administration no longer refers to its Phase 2b clinical trial for a potential treatment for hypoplastic left heart syndrome (HLHS) as pivotal.

Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced ...

Treatment with treprostinil led to significant and sustained improvements in children with PH associated with lung disease, ...

When it comes to heart health, running is one of the most common ways people exercise their cardiac muscles. However, ...